Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Recipient 18 years of age or older~* Recipient with chronic end-stage liver disease~* Deceased donor liver transplant~* Recipient capable of providing written informed consent~* Whole organ graft from donors aged 60 years or older~Exclusion Criteria:~* Fulminant liver failure~* Objection by any other member of the retrieval team~* Split-liver grafts~* Donor that has received total parenteral nutrition within 24hr of organ retrieval Donors from whom the pancreas and/or small bowel are also being retrieved

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Deceased liver donors that are randomized to this arm will receive the Glucose/Ischemic Preconditioning pre-treatment intra-operatively prior to starting cold preservation of the organ
- 2 (Type: NO_INTERVENTION): Neither donors nor recipients receive any intervention. All procedures will be performed according to our institution's standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).